JW Pharmaceutical Corp (001067) — Cash Flow Reinvestment Rate
JW Pharmaceutical Corp (001067) has a Cash Flow Reinvestment Rate of 0.44x as of September 2025, reinvesting ₩20.68 Billion (capex ₩9.80 Billion plus investments ₩10.88 Billion) from operating cash flow of ₩46.92 Billion. Check JW Pharmaceutical Corp cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
JW Pharmaceutical Corp Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for JW Pharmaceutical Corp across 10 annual periods. Explore long-term investment intensity of JW Pharmaceutical Corp to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for JW Pharmaceutical Corp (2014–2024)
Year-by-year capital reinvestment analysis for JW Pharmaceutical Corp. For live market cap and broader valuation context, see JW Pharmaceutical Corp (001067) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.75x | ₩59.86 Billion | ₩79.39 Billion | ₩28.14 Billion | ▼ -37.1% |
| 2023 | 1.20x | ₩104.49 Billion | ₩87.16 Billion | ₩40.71 Billion | ▲ +87.7% |
| 2022 | 0.64x | ₩36.26 Billion | ₩56.76 Billion | ₩9.92 Billion | ▲ +35.5% |
| 2021 | 0.47x | ₩8.55 Billion | ₩18.12 Billion | ₩7.47 Billion | ▼ -60.0% |
| 2020 | 1.18x | ₩74.34 Billion | ₩63.05 Billion | ₩12.39 Billion | ▲ +529.0% |
| 2019 | 0.19x | ₩10.41 Billion | ₩55.53 Billion | ₩9.28 Billion | ▼ -29.3% |
| 2018 | 0.27x | ₩13.82 Billion | ₩52.11 Billion | ₩8.64 Billion | ▲ +17.9% |
| 2017 | 0.22x | ₩7.52 Billion | ₩33.45 Billion | ₩7.50 Billion | ▼ -91.9% |
| 2016 | 2.79x | ₩18.79 Billion | ₩6.74 Billion | ₩10.02 Billion | ▲ +131.2% |
| 2014 | 1.21x | ₩8.78 Billion | ₩7.28 Billion | ₩6.93 Billion | — |